80 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
. During and after your engagement and employment, you also shall reasonably cooperate with the Company in connection with any investigation or review
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
of the Company at mutually convenient times. During and after your engagement and employment, you also shall reasonably cooperate with the Company
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
(including continued employment or engagement or performance conditions) and terms as the Committee deems appropriate.
(bb) “Restricted Stock Unit … ) is subject to such conditions (including continued employment or engagement or performance conditions) and terms as the Committee deems appropriate.
(cc
8-K
EX-10.25
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
hereunder, Oruka will pay Consultant twenty thousand US Dollars ($20,000.00) for up to forty (40) hours per week over an anticipated engagement
425
mb6g il46wznc0nels3h
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
vvhe27z3 h6yk58
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am